Close
Close
Understanding Myelofibrosis
213 views
2.66666666667
2.7 from 6 votes

Myelofibrosis is a disorder of the bone marrow, in which the marrow is replaced by fibrous (scar) tissue. When the bone marrow is scarred, it cannot make enough blood cells. This leads to anemia, weakness, fatigue, and often an enlarged spleen.  Myelofibrosis is an uncommon type of chronic leukemia — a cancer that affects the blood-forming tissues in the body. Myelofibrosis belongs to a group of diseases called myeloproliferative disorders. The condition occurs when blood stem cells develop somatic mutations in the JAK2, MPL, CALR, and TET2 genes. Other genes may also be involved. The condition is generally not inherited.  Although myelofibrosis can occur at any age, it typically develops after the age of 50. In most cases, myelofibrosis gets progressively worse. Treatment is aimed at relieving signs and symptoms and may include medications, blood transfusions, chemotherapy, radiation therapy and surgery.

by Abidemi Uruejoma
24 views 3 days ago
by Abidemi Uruejoma
36 views 1 week ago
by Abidemi Uruejoma
46 views 2 weeks ago
by Abidemi Uruejoma
67 views 3 weeks ago
by Abidemi Uruejoma
118 views 2 months ago
by Scott Harwood
119 views 2 months ago
by Scott Harwood
114 views 2 months ago
by Scott Harwood
158 views 2 months ago
2.66666666667
2.7 from 6 votes
Free Newsletter
Find a Clinical Trial
Related Videos